Rhabdomyolysis After COVID-19
Authors: Navya Kataria, Abel Devadass, Lana Sundac, Laura De Souza, Nabeel Sheikh, Samantha Ng, Scott Campbell, Yishen Wang, Ross S. Francis
Correspondence: ross.francis@health.qld.gov.au
Published online: 14 July 2026
Abstract
We report a case of a kidney transplant recipient who presented with generalised muscle pain, weakness and brown urine discoloration in the setting of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Investigations demonstrated rhabdomyolysis with elevated creatine kinase levels and severe acute kidney injury (AKI). A muscle biopsy was consistent with an immune-mediated necrotising myositis. The patient received intravenous fluids, remdesivir and haemodialysis, with subsequent resolution of muscle injury and recovery of kidney function. This case indicates the potential for severe myositis to develop in patients with SARS-CoV-2 infection with the potential for rhabdomyolysis and AKI to occur.
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Hadar Mudrik-Zohar, Tim Cutfield, Susan Morpeth, Thomas Hills, Eamon Duffy, Laura J. Edwards, Allen C. Cheng, Steven Y. C. Tong
Lesson From Practice: Not Gone, Should Not Be Forgotten: Recognising PIMS-TS Cases in a Post-Pandemic World
Rana Sawires, Anneke Engwerda, Mehyar Khair Baik, Philip N. Britton, David P. Burgner
Effectiveness of COVID‐19 vaccine boosters for reducing COVID‐19 mortality among people aged 65 years or older, Australia, August 2023 – February 2024: a retrospective observational cohort study
Bette Liu, Anish Scaria, Sandrine Stepien, Kristine Macartney
The long tail of COVID‐19
Elizabeth Zuccala
Medications for early treatment of COVID‐19 in Australia
Adam Polkinghorne, James M Branley
COVID‐19: estimated number of deaths if Australia had experienced a similar outbreak to England and Wales
Fiona Stanaway, Les M Irwig, Armando Teixeira‐Pinto, Katy JL Bell